TITLE:
      Infusion Laboratory: Protocol 1 - Selegeline - 2
SUMMARY:
      The purpose of this study is to determine the effects of selegiline on the subjective and
      physiological effects of cocaine challenge in chronic crack abusers, and to evaluate
      clinical safety issues pertaining to selegeline, to cocaine and their interaction in a
      chronic crack dependent population.
DETAILED DESCRIPTION:
      To develop a medication for the treatment of cocaine addiction using a medical human
      physio-neuro-psycho-immunology laboratory setting. To characterize this cocaine abusing
      population on a variety of psychological and physicologically measures over time from
      withdrawal through pere and post cocaine administration. To determine the effects of
      selegeline on the subjective and physiological effects of cocaine challenge in chronic crack
      abusers. To evaluate clinical safety issues pertaining to selegeline, to cocaine and their
      interaction in a chronic crack dependent population.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F, ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
